← Leaderboards
Deborah Anne Dean
Children'S Hospital &Res Ctr At Oakland
$16,812,344
Attributed
$31,113,249
Total exposure
17
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,113,249 · 17
By mechanism
R01$18,315,517 · 6
R44$8,871,283 · 4
R43$1,474,046 · 2
R41$1,199,496 · 2
R56$641,677 · 1
R21$468,789 · 1
Top collaborators
- Timothy D. Read23 shared
- Richard F Selden12 shared
- Debkishore Mitra6 shared
- Ivan Dimov2 shared
- Michael Sejr Vajdy2 shared
- David Marcelo Ojcius1 shared
- Sheena Devika Singh1 shared
Others in their field
Top investigators on “Chlamydia Trachomatis”
- Bala Raja · Luminostics, Inc.$28,624,460
- Michael N Starnbach · Harvard University (Medical School)$24,145,144
- Toni Darville · Univ Of North Carolina Chapel Hill$20,345,023
- Guangming Zhong · University Of Texas Hlth Sci Ctr San Ant$19,835,841
- Raphael H. Valdivia · Duke University$12,244,009
- William M Geisler · University Of Alabama At Birmingham$11,551,351
Research focus
Chlamydia TrachomatisDesignSamplingInfectionSexually Transmitted DiseasesPathogenOrganismBasePelvic Inflammatory DiseaseDiagnosticGenomeGenomicsChlamydiaTransmission ProcessInfertilityMedicalVaginaDetectionGeneticEctopic PregnancyWomanLeadAntibioticsFemale
Grant awards (57)
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA$795,885
R01 · FY2025 · AI · contact PI
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA$798,995
R01 · FY2024 · AI · contact PI
Natural History of C. trachomatis urogenital and rectal infections$783,622
R01 · FY2024 · AI · contact PI
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA$798,995
R01 · FY2023 · AI · contact PI
Natural History of C. trachomatis urogenital and rectal infections$795,388
R01 · FY2023 · AI · contact PI
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$982,993
R44 · FY2022 · AI
Natural History of C. trachomatis urogenital and rectal infections$800,015
R01 · FY2022 · AI · contact PI
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA$796,353
R01 · FY2022 · AI · contact PI
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$991,343
R44 · FY2021 · AI
Natural History of C. trachomatis urogenital and rectal infections$800,761
R01 · FY2021 · AI · contact PI
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea$999,228
R44 · FY2020 · AI
Natural History of C. trachomatis urogenital and rectal infections$816,577
R01 · FY2020 · AI · contact PI
C. trachomatis within-host genomic diversity and transmission between female anatomic sites$207,016
R21 · FY2020 · AI
C. trachomatis within-host genomic diversity and transmission between female anatomic sites$261,773
R21 · FY2019 · AI
Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$776,968
R44 · FY2018 · AI
Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae$716,689
R44 · FY2017 · AI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics$696,136
R44 · FY2017 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,044,525
R01 · FY2016 · AI · contact PI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics$707,926
R44 · FY2016 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,058,086
R01 · FY2015 · AI · contact PI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnos$299,748
R41 · FY2015 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,071,188
R01 · FY2014 · AI · contact PI
A Rapid Point-of-care Diagnostic for C. trachomatis STDs$1,000,000
R44 · FY2014 · AI
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnos$299,748
R41 · FY2014 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,030,900
R01 · FY2013 · AI · contact PI
A Rapid Point-of-care Diagnostic for C. trachomatis STDs$1,000,000
R44 · FY2013 · AI
A novel vaccine against vaginal Chlamydia trachomatis$300,000
R41 · FY2013 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,246,735
R01 · FY2012 · AI · contact PI
A Rapid Point-of-care Diagnostic for C. trachomatis STDs$1,000,000
R44 · FY2012 · AI
A novel vaccine against vaginal Chlamydia trachomatis$300,000
R41 · FY2012 · AI
A Rapid Point-of-care Diagnostic for Neisseria gonorrhoeae STDs$294,001
R43 · FY2012 · AI
A Rapid Point-of-care Diagnostic for Neisseria gonorrhoeae STDs$300,000
R43 · FY2011 · AI
The influence of negative regulators of inflammation on C. trachomatis infections$641,677
R56 · FY2010 · AI · contact PI
A Rapid Point-of-care Diagnostic for C.trachomitis STDs$430,463
R43 · FY2010 · AI
Pathogenesis of persistent C. trachomatis STDs$31,798
R03 · FY2010 · TW · contact PI
A Rapid Point-of-care Diagnostic for C.trachomitis STDs$449,582
R43 · FY2009 · AI
Pathogenesis of persistent C. trachomatis STDs$70,915
R03 · FY2009 · TW · contact PI
C. trachomatis genomics, strain typing, and evolution$533,583
R01 · FY2008 · AI · contact PI
Pathogenesis of persistent C. trachomatis STDs$39,728
R03 · FY2008 · TW · contact PI
C. trachomatis genomics, strain typing, and evolution$526,602
R01 · FY2007 · AI · contact PI
Pathogenesis of Persistent Chlamydial STDs$236,025
R01 · FY2007 · AI · contact PI
C. trachomatis genomics, strain typing, and evolution$97,964
R01 · FY2007 · AI · contact PI
C. trachomatis genomics, strain typing, and evolution$512,250
R01 · FY2006 · AI · contact PI
Pathogenesis of Persistent Chlamydial STDs$243,074
R01 · FY2006 · AI · contact PI
C. trachomatis genomics, strain typing, and evolution$104,640
R01 · FY2006 · AI · contact PI
C. trachomatis genomics, strain typing, and evolution$503,758
R01 · FY2005 · AI
Pathogenesis of Persistent Chlamydial STDs$251,928
R01 · FY2005 · AI
C. trachomatis genomics, strain typing, and evolution$505,829
R01 · FY2004 · AI
PATHOGENESIS OF CHLAMYDIAL OCULAR INFECTIONS$309,400
R01 · FY2004 · EY
Pathogenesis of Persistent Chlamydial STDs$254,933
R01 · FY2004 · AI
PATHOGENESIS OF CHLAMYDIAL OCULAR INFECTIONS$309,400
R01 · FY2003 · EY
Pathogenesis of Persistent Chlamydial STDs$93,391
R01 · FY2003 · AI
PATHOGENESIS OF CHLAMYDIAL OCULAR INFECTIONS$59,644
R01 · FY2003 · EY
PATHOGENESIS OF CHLAMYDIAL OCULAR INFECTIONS$309,400
R01 · FY2002 · EY
PATHOGENESIS OF CHLAMYDIAL OCULAR INFECTIONS$309,400
R01 · FY2001 · EY
PATHOGENESIS OF CHLAMYDIAL OCULAR INFECTIONS$309,400
R01 · FY2000 · EY
MOLECULAR TYPING OF RECURRENT CHLAMYDIAL STDS$206,871
R01 · FY2000 · AI